☒
|
Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934
|
☐
|
Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934
|
Delaware
|
52-2007292
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification Number)
|
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
|
Title of Class
|
Trading Symbol
|
Name of Each Exchange on Which Registered
|
Common Stock, $0.01 par value
|
PALI
|
Nasdaq Capital Market
|
Large accelerated filer ☐
|
Accelerated filer ☐
|
Non-accelerated filer ☒
|
Smaller reporting company ☒
|
Number
|
Exhibit Title
|
Filed
Herewith |
||
X
|
||||
X
|
||||
101.INS
|
XBRL Instance Document
|
|||
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
|||
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|||
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|||
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
|||
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
PALISADE BIO, INC.
|
||
Date: September 14, 2021
|
/s/ Thomas M. Hallam
|
|
Thomas M. Hallam, PhD, Chief Executive Officer
|
||
(Principal Executive Officer)
|
Date: September 14, 2021
|
/s/ J.D. Finley
|
|
J.D. Finley, Chief Financial Officer
|
||
(Principal Financial Officer)
|
Exhibit 31.1
CERTIFICATION PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Thomas M. Hallam, certify that:
1. |
I have reviewed this Quarterly Report on Form 10-Q/A of Palisade Bio, Inc.; and |
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: September 14, 2021 |
By: |
/s/ Thomas M. Hallam |
|
Thomas M. Hallam |
|||
Chief Executive Officer |
|||
(Principal Executive Officer) |
Exhibit 31.2
CERTIFICATION PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, J.D. Finley, certify that:
1. |
I have reviewed this Quarterly Report on Form 10-Q/A of Palisade Bio, Inc.; and |
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: September 14, 2021 |
By: |
/s/ J.D. Finley |
|
J.D. Finley |
|||
Chief Financial Officer |
|||
(Principal Financial Officer) |